Ajay Bagga offers a clear strategy for Indian markets. He advises waiting for real AI revenue in IT. Pharma remains a strong investment due to multiple advantages. Defence is a long-term play with significant growth potential. Bagga highlights shipbuilders and drone makers in defence. Investors should focus on AI revenue in IT and selective opportunities in pharma and defence.